Total
0
Shares
Image Sourced ShutterStock
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • MedAdvisor and Zuellig Pharma have signed the first customer for MedExpress Drugstores
  • The company will provide digital medication platforms to more than 1.5 million customers across the Philippines

MedAdvisor Limited, and its 50:50 joint venture with Zuellig Pharma, has signed its first customer, MedExpress Drugstores.

Serving 1.5 million customers and 50 hospitals nationwide MedExpress is the leading delivery and hospital outpatient pharmacy chain in the Philippines.

This agreement is for Zuellig to provide digital programs to its customers via SMS as well as a ‘MedExpress’ mobile medication management app. This app will help customers track their medication and refills from MedExpress.

Fill-My-Scripts automatically reminds patients when to refill their recurring scripts and chases them up if they forget. MedAdvisor will send a message providing information if the medication is running low.

The automated message will only send these messages if the script hasn’t been filled out five days before the medication runs out. If the scripts are up to date MedAdvisor will remind on the day and again when the patient has been without medication for three days.

With Tap-To-Refill patients can order prescriptions online so they are ready to collect at a pharmacy without any waiting times. Repeat prescriptions can be preordered and dispensed at a local pharmacy for pickup.

Take-My-Meds reminds patients when to take specific medications each day and at the appropriate time. This feature alerts their phone every time medication is due to be taken and the notifications include details of exactly which medications are due at which time.

The agreement is set for an initial 18 month period beginning from when that app is available and can be renewed for further 24 month extensions after.

Please find announcement here  

MDR by the numbers
More From The Market Herald
Biogene Technology (ASX:BGT) - CEO, Richard Jagger

" Bio-Gene (ASX:BGT) shares close green on new commercial deal

Bio-Gene Technology (BGT) has executed a licence and development agreement with Evergreen Garden Care.
Beam Communications (ASX:BCC) - Chairman, Simon Wallace

" Beam Communications (ASX:BCC) receives orders for 12,000 ZOLEO units

Beam Communications (BCC) has received orders for 12,000 extra ZOLEO devices manufactured under its joint venture entity.
Botanix Pharmaceuticals (ASX:BOT) - President & Executive Chairman, Vince Ippolito

" Botanix Pharmaceuticals (ASX:BOT) progresses clinical programs

Botanix Pharmaceuticals (BOT) progressed a number of clinical programs during the September quarter.
Recce Pharmaceuticals (ASX:RCE) - CEO, James Graham

" Recce Pharmaceuticals (ASX:RCE) receives ethics approval to begin R327 trial

Recce Pharmaceuticals (RCE) has received Human Research Ethics Committee (HREC) approval to begin its phase one intravenous (IV) trial of RECCE327 (R327).